Target intelligence / Profile preview

Intestinal epithelial cell regeneration

Molecular classification
Other (Biological process), Not a molecular entity
01

Overview

Intestinal epithelial cell regeneration is a dynamic and continuous process in which the intestinal epithelial lining is renewed every few days, primarily by stem cells residing at the crypt base (crypt base columnar cells, identified by Lgr5 expression)[1][2][3][5]. These stem cells proliferate, differentiate into various epithelial cell types, and migrate along the crypt-villus axis to replace aging or damaged cells. The regenerative process is critical for maintaining gut barrier function and responding to stresses such as infections, inflammation, and physical injury. Paneth cells, present in the crypts, secrete signaling molecules (e.g., WNT, EGF, Notch ligands) that maintain the stem cell niche, and can themselves dedifferentiate to aid regeneration after injury[1][3]. Multiple signaling pathways—including WNT, BMP, EGF, FGF, and TGF-β—regulate the self-renewal and differentiation of ISCs[4][5][6]. Disruption of these pathways leads to gastrointestinal diseases, and components of the regenerative process are under investigation as targets in disorders such as inflammatory bowel disease and colorectal cancer, though "intestinal epithelial cell regeneration" itself is a process, not a distinct molecular therapeutic target[4]. In summary, "intestinal epithelial cell regeneration" is a biological process mediated by stem cells and supporting molecular pathways, and not a discrete molecule or canonical druggable target.

Other names
Intestinal epithelial regenerationIntestinal epithelial renewalGut epithelial regenerationIntestinal mucosal healing
02

Biological functions

Cell proliferationCell differentiationTissue regenerationHomeostasisBarrier function
03

Disease associations

Inflammation (e.g., inflammatory bowel disease)Cancer (e.g., colorectal cancer)Infection (epithelial repair after gut infection)Other (radiation injury, ischemia, physical trauma)
04

Safety considerations

Therapeutic manipulation of intestinal regeneration may risk tumorigenesis (dysregulated stem cell proliferation)Altered regeneration can contribute to fibrosis or impaired barrier integrity
05

Interacting drugs

WNT agonists

3 more in the full profile.

06

Biomarkers

Lgr5Bmi1TertHopxLrig1OLFM4Paneth cell markers

Beyond the preview

Go deeper on Intestinal epithelial cell regeneration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial cell regeneration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call